top of page

The head of Novo Nordisk's Bio Innovation Hub on collaborating to modify cardiometabolic diseases

Uli Stilz talks about the collaborations Novo is making with institutions and companies to work on science that might slow or reverse the progression of cardiometabolic diseases.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page